BDMAI

Infinite Right-to-Left Scrolling Marquee
Latest Circulars

Availability of QC Manpower trained in BDMA T & T Center

Sectoral Plan for Effective Logistics – Pharma Sector

BDMAI News Letter – Material contribution by Members

Interaction with USP, India team with our Member companies on 9.1.2025 at 2.00 p.m.

Pharma MSME Industry Meet – 24.1.2025

Delays in obtaining URN / Permission for Destruction of Controlled Substances from NCB

MOU Signing Ceremony between BDMAI and Telangana Council of Higher Education

Implementation of Schedule M – Online Demo by CDSCO for filling application on 14th February 2025

Allotment of land in Green Pharma City, Telangana

Launch of a Scheme for Promotion of Research & Innovation in Pharma MedTech (PRIP) Sector by Department of Pharmaceuticals, Govt. of India

New Guidelines for obtaining NoC for Export of Unapproved/Approved New Drugs

Free In-House Up-Skilling Programme by LSSSDC for Employees BDMAI Member companies

ICH Guidelines- Q7- Telugu Translated version

Special offer by Avila International – Travel Package – CPhI China

Online Application for implementation of Schedule M

Simplification of license procedure to manufacture new drug or investigational new drug for clinical trial or bioavailability or bioequivalence study or for examination, test and analysis

Workshop for Bench Chemists

Nomination for Internal Committees of BDMAI

Availability of QC Manpower trained in BDMA T & T Center

Sectoral Plan for Effective Logistics – Pharma Sector

BDMAI News Letter – Material contribution by Members

Interaction with USP, India team with our Member companies on 9.1.2025 at 2.00 p.m.

Pharma MSME Industry Meet – 24.1.2025

Delays in obtaining URN / Permission for Destruction of Controlled Substances from NCB

MOU Signing Ceremony between BDMAI and Telangana Council of Higher Education

Implementation of Schedule M – Online Demo by CDSCO for filling application on 14th February 2025

Allotment of land in Green Pharma City, Telangana

Launch of a Scheme for Promotion of Research & Innovation in Pharma MedTech (PRIP) Sector by Department of Pharmaceuticals, Govt. of India

New Guidelines for obtaining NoC for Export of Unapproved/Approved New Drugs

Free In-House Up-Skilling Programme by LSSSDC for Employees BDMAI Member companies

ICH Guidelines- Q7- Telugu Translated version

Special offer by Avila International – Travel Package – CPhI China

Online Application for implementation of Schedule M

Simplification of license procedure to manufacture new drug or investigational new drug for clinical trial or bioavailability or bioequivalence study or for examination, test and analysis

Workshop for Bench Chemists

Nomination for Internal Committees of BDMAI

Objectives

“The Association works   for consolidation  of  the  gains of the industry and serves  as  a catalyst between Government and the  Industry  on the  various issues for the growth of the Industry”:

  • Strengthening India’s Pharmaceutical Industry

    • Build on India’s existing strength in manufacturing and distribution.
    • Significantly enhance R&D capabilities.
    • Become a leading player in the global pharmaceutical market.

 

  • Serving as a Common Forum

    • Promote discussions on key issues affecting the Bulk Drug Industry in India.
    • Provide a platform for members to formulate collective views on national, economic, financial, and commercial policies impacting industry growth.

 

  • Encouraging Collaboration Among Members

    • Foster mutual help and cooperation among members.

 

  • Advocacy & Representation

    • Represent members’ collective opinions on industry-related matters.
    • Engage with State and Central Government authorities to influence policy decisions affecting the bulk drug industry.

 

  • Information Sharing & Publications

    • Disseminate relevant information to members.
    • Publish and circulate papers, periodicals, books, and circulars beneficial to the industry.

 

  • Innovation & Research

    • Promote the discovery and investigation of inventions beneficial to the Bulk Drug Industry.
    • Support the development of new drugs and process improvements.

 

  • Market Development

    • Develop strategies to enhance indigenous and export markets for Indian Bulk Drugs.

 

  • Dispute Resolution

    • Provide arbitration and settlement services for commercial disputes between members and non-members (with mutual consent).

 

  • Quality & Research Facilities

    • Establish and maintain libraries and laboratories for testing bulk drugs and allied products.
    • Set up R&D centers for drug development and process improvements.
    • Develop Hi-tech Research & Training Centers for industry advancement.

 

  • Funding & Support

    • Accept donations and contributions from government bodies, philanthropic institutions, organizations like FAO, WHO, and individuals.

 

  • Legal & General Activities

    • Undertake all lawful activities aligned with the Association’s objectives.

© 2021 Templately copyright all right reserved